Bertrand H, Forin V
Service de chirurgie orthopédique, hôpital d'enfants Armand-Trousseau, 26, avenue du Docteur-A.-Netter, 75012 Paris, France.
Ann Readapt Med Phys. 2003 Jul;46(6):346-52. doi: 10.1016/s0168-6054(03)00107-7.
The aim of this study is to review the literature to indications of botulinum toxin type A in children.
We review the international literature from 1990 to 2002 by querying the Pubmed database with the keywords "children" and "botulinum toxin".
Two hundred and forty-eight articles are retrieved. We selected the most relevant 64 articles among them. Several questions remain pending: which optimal dose, which periodicity for injections, which optimal age to prolong efficiency? The main criteria to estimate efficiency is functional ability improvement. No significant side effects are noted. The main use of botulinum toxin is the management of the spastic lower limb in cerebral palsy.
This review of the literature makes it possible to specify the interests and the operational limits of botulinum toxin in the child. Its effectiveness with the upper limb is not proven. The other indications remain to be studied in a more precise way.
This review shows many studies give the indications of botulinum toxin in children. The main indication is the lower limb spaticity in cerebral palsy. New prospective and double-blind studies should be performed with larger samples.
本研究旨在回顾有关A型肉毒杆菌毒素在儿童中的应用指征的文献。
我们通过在Pubmed数据库中查询关键词“儿童”和“肉毒杆菌毒素”,回顾了1990年至2002年的国际文献。
检索到248篇文章。我们从中挑选出最相关的64篇文章。仍有几个问题悬而未决:最佳剂量是多少、注射周期是多久、延长疗效的最佳年龄是多少?评估疗效的主要标准是功能能力的改善。未观察到明显的副作用。肉毒杆菌毒素的主要用途是治疗脑瘫患儿的下肢痉挛。
对文献的回顾使得明确肉毒杆菌毒素在儿童中的益处和操作限制成为可能。其在上肢的有效性尚未得到证实。其他应用指征仍有待更精确地研究。
本次回顾表明,许多研究给出了肉毒杆菌毒素在儿童中的应用指征。主要指征是脑瘫患儿的下肢痉挛。应开展新的前瞻性双盲研究,样本量要更大。